Impact of Drug-Coated Balloon Inflation Time on Outcome After Percutaneous Coronary Intervention: An Observational Study From SCAAR.
S, v.K., M, Z., A, H., T, R., E, O., S, Z., D, E., TT, R., & MA, M. (2026). Impact of Drug-Coated Balloon Inflation Time on Outcome After Percutaneous Coronary Intervention: An Observational Study From SCAAR.. Journal of the American Heart Association. https://doi.org/10.1161/JAHA.125.047354
S vK, M Z, A H, T R, E O, S Z, et al. Impact of Drug-Coated Balloon Inflation Time on Outcome After Percutaneous Coronary Intervention: An Observational Study From SCAAR.. Journal of the American Heart Association. 2026; doi: 10.1161/JAHA.125.047354
S vK, M Z, A H, et al. Impact of Drug-Coated Balloon Inflation Time on Outcome After Percutaneous Coronary Intervention: An Observational Study From SCAAR.[J]. Journal of the American Heart Association. 2026. DOI: 10.1161/JAHA.125.047354.
@article{s2026,
author = {von Koch S and Zhou M and Håkansson A and Råmunddal T and Omerovic E and Zwackman S and Erlinge D and Rissanen TT and Mohammad MA},
title = {Impact of Drug-Coated Balloon Inflation Time on Outcome After Percutaneous Coronary Intervention: An Observational Study From SCAAR.},
journal = {Journal of the American Heart Association},
year = {2026},
doi = {10.1161/JAHA.125.047354},
note = {PMID: 42535531},
}
TY - JOUR AU - von Koch S AU - Zhou M AU - Håkansson A AU - Råmunddal T AU - Omerovic E AU - Zwackman S AU - Erlinge D AU - Rissanen TT AU - Mohammad MA TI - Impact of Drug-Coated Balloon Inflation Time on Outcome After Percutaneous Coronary Intervention: An Observational Study From SCAAR. T2 - Journal of the American Heart Association PY - 2026 DO - 10.1161/JAHA.125.047354 AN - PMID:42535531 ER -
BACKGROUND: There are limited data guiding the optimal inflation time for coronary drug-coated balloons. The aim of this study was to assess the clinical efficacy of an inflation time of ≥30 seconds compared with <30 seconds. METHODS: We conducted an observational nationwide analysis using the SCAAR (Swedish Coronary Angiography and Angioplasty Registry) to identify all patients undergoing percutaneous coronary intervention with drug-coated balloons and their inflation times. Outcomes were assessed at 1 year using Kaplan-Meier estimates and adjusted Cox regression. RESULTS: The <30-second group comprised 412 patients, and the ≥30-second group 10 826 patients. Patients in the <30-second group presented more often with lesions in proximal segments. After a 1-year follow-up, ≥30 seconds was associated with lower rates of target segment revascularization compared with <30 seconds (3.2% versus 6.4%, adjusted hazard ratio [HR], 0.47 [95% CI, 0.32-0.69], P≤0.001) and target vessel myocardial infarction (1.8% versus 5.3%, adjusted HR, 0.32 [95% CI, 0.21-0.50], P≤0.001). No difference was observed for all-cause mortality. CONCLUSIONS: In this analysis, including 11 238 patients undergoing PCI with drug-coated balloons, ≥30 second inflation time was associated with improved outcomes compared with a shorter inflation time.